Markets

U.S. open in 9 hrs, 58 mins

DJIA

10,464.40

30.69

0.29%

NASDAQ

2,176.05

6.87

0.32%

S&P 500

1,110.63

4.98

0.45%

10yr Note

100.844

0.25

0.25%

FTSE 100

5,194.13

-170.68

3.18%

Nikkei 225

9,197.67

-185.57

1.98%

Hang Seng

21,464.90

-745.51

3.36%

Euro (in USD)

1.501

-0.0128

0.85%

Yen (per USD)

86.41

-0.92

1.05%

Gold (Dec)

1,185.80

-1.20

0.10%

Oil (Jan)

75.90

-2.06

2.64%

BUSINESS NEWS

INVESTING

PERSONAL FINANCE AT WALLETPOP

SMALL BUSINESS

Genzyme Announces Results of Phase 2/3 Trial of Advanced Phosphate Binder

Business Wire

posted: 8 DAYS 16 HOURS AGO

Text SizeAAA

Genzyme Corporation (Nasdaq: GENZ) today reported results of a phase 2/3 study of its advanced phosphate binder (APB). The trial met its primary endpoint, which was to show that the APB lowered phosphate levels effectively compared to placebo. However, the APB did not show a significant improvement in phosphate lowering compared to Genzyme

2009-11-18 06:55:00

COMMENTS ( 0 )

Newest First